Health & Biotech
ASX Health Stocks: Mesoblast raise signals potential comeback for biotechs
Kazia says diversification is the key to drug development
ASX Health Stocks: Avita tumbles 16pc as RECELL study results disappoint investors
Weed Week: Ice-T plans to open dispensary and Snoop Dogg’s venture capital firm backs weed snacks
Neuroscientific Biopharmaceutical kicks off clinical trials for MS and Alzheimer’s treatment
Medlab’s NRGBiotic depression patent formally accepted by European watchdog
Health Kick Podcast: How Osteopore is innovating in the area of bone and tissue regeneration
ASX Health Stocks: Patrys says brain cancer drug is effective; HitIQ awarded Aussie patent
Dimerix moves fast to patent DMX-700 after ‘important new drug discovery’
Incannex powers into addiction treatment following APIRx deal to takeover novel patented treatments
Leading health apps taking the Aussie wellbeing industry by storm
ASX Health Stocks: Acrux and Lumos await potential approvals from the US FDA
Race Oncology’s breakthrough in Zantrene offers huge market opportunity in chemotherapy
Medlab’s NanoCelle tech hits a bullseye for future drug-delivery
Incannex completes landmark deal, positioning as a global leader in medicinal cannabis and psychedelics
Stock Insiders: MGC Pharmaceuticals’ ‘golden blanket’ combines multiple elements for better patient efficacy
ASX Health Stocks: Emyria takes its MDMA-inspired drugs to the next level
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
